SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/8E89BFA52530232C06F8C14AC9A15DE01B3FF827632B1B635D5DECE5AC1423DC62D26909A9F3DCD7E9C742D4F2CA5516>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/8E89BFA52530232C06F8C14AC9A15DE01B3FF827632B1B635D5DECE5AC1423DC62D26909A9F3DCD7E9C742D4F2CA5516
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8E89BFA52530232C06F8C14AC9A15DE01B3FF827632B1B635D5DECE5AC1423DC62D26909A9F3DCD7E9C742D4F2CA5516
http://www.w3.org/2000/01/rdf-schema#comment
"These results suggest aberrant Claudin 7 alpha - and beta-catenin expression and/or localisation patterns may be putative markers for distinguishing localised prostate cancer from aggressive metastatic disease when used collectively."
xsd:string
http://purl.uniprot.org/uniprot/#_D6B5347973BC5D155EB6A80A111694308DD674C0679BB44378A06B049DD6D7C573722F7F5C47249A5B3BE2849EBC7FDE
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/8E89BFA52530232C06F8C14AC9A15DE01B3FF827632B1B635D5DECE5AC1423DC62D26909A9F3DCD7E9C742D4F2CA5516
http://purl.uniprot.org/uniprot/Q9UI47
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8E89BFA52530232C06F8C14AC9A15DE01B3FF827632B1B635D5DECE5AC1423DC62D26909A9F3DCD7E9C742D4F2CA5516
http://purl.uniprot.org/uniprot/#_Q9UI47-mappedCitation-24358122
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8E89BFA52530232C06F8C14AC9A15DE01B3FF827632B1B635D5DECE5AC1423DC62D26909A9F3DCD7E9C742D4F2CA5516